Streetbeat News

Partnerships

CHH

TOST

Toast (NYSE:TOST) has announced a collaboration with Choice Hotels International (NYSE:CHH) to make its Toast for Hotel Restaurants technology a brand standard for Cambria Hotels and Radisson, two of Choice's upscale brands. The technology aims to digitalize guest dining experiences and streamline operations, with full implementation expected by summer 2025 for Cambria and early 2026 for Radisson. The partnership will include various digital dining solutions and integration with property management systems to enhance food and beverage sales, kitchen efficiency, and guest satisfaction.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:20 pm

NVEI

Nuvei Corporation (NASDAQ:NVEI) announces the global rollout of its enhanced omnichannel payments solution, now available outside North America. This solution unifies online and offline payments, offering businesses from various sectors like retail and hospitality, a seamless checkout experience tailored for each channel. It combines card-present and card-not-present technology for eCommerce, mobile, and in-store transactions, enabling unified payment acceptance. Additional features include comprehensive analytics, streamlined operations through a common API, and flexible retail payments hardware options. Nuvei's global reach and local acquiring capabilities in 50 countries, along with connectivity to 680 alternative payment methods, support international market expansion.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:17 pm

ORCL

Oracle Cloud Infrastructure (OCI) has received FedRAMP approval for over 16 new services and features, enhancing AI, DevOps, and security for U.S. government customers. This expands Oracle's FedRAMP authorized services to 93, available in its U.S. government regions. The approval includes a range of services from OCI DevOps Service to Oracle Big Data Service, and introduces new capabilities and features to existing services. Oracle used a FedRAMP recognized third-party assessment organization for the approval process.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:14 pm

PCRX

Pacira BioSciences, Inc. (NASDAQ:PCRX) has entered into a national group purchasing agreement with Premier, Inc. for its non-opioid pain management solution, EXPAREL. This agreement, effective January 1, 2024, allows Premier members to access special pricing and terms for EXPAREL, aiming to improve patient care and reduce healthcare costs. The collaboration aligns with both companies' goals of advancing innovation and patient safety while expanding Pacira's reach in the U.S. healthcare market.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:11 pm

DXR

Daxor Corporation (NASDAQ:DXR) reported growth in Q4 2023 through new sales of its BVA-100 Blood Volume Diagnostic analyzers to hospital systems and increased utilization at existing accounts across the U.S. The company's ezBVA Lab Service was highlighted as a key factor in driving this growth and adoption. Sales wins included analyzer purchases and rentals at major healthcare systems in Georgia, Wisconsin, and a multi-state academic health center, as well as an extension of the ezBVA Lab service in New Jersey. CEO Michael Feldschuh emphasized the company's focus on broadening commercial reach and improving patient outcomes.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:06 pm

IRON

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company, announced the appointment of Jean Franchi as Chief Financial Officer and the promotion of Jonathan Yu to Chief Operating Officer. Franchi brings over 30 years of finance leadership experience, having previously served as CFO for several biotechnology companies. She will be responsible for finance, investor relations, and leading the company's financial strategy. The company also granted Franchi an inducement equity award in line with NASDAQ Listing Rule 5635(c)(4).

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:05 pm

AAPL

MSFT

Rubén Caballero, a former Apple Inc. executive, has reportedly left his position at Microsoft Corp., where he was leading device engineering for mixed reality and AI since 2020. His departure, not officially announced, comes as Microsoft shifts focus towards artificial intelligence, canceling several hardware projects. This move could influence Microsoft's future direction in mixed reality and AI, areas where the company has been making significant strides.

Portfolio Pulse from Benzinga Neuro

February 07, 2024 | 12:49 pm

TRIN

Trinity Capital has announced a commitment of $20 million in equipment financing to Formlogic, aiming to support Formlogic's growth and expansion efforts.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 12:41 pm

BBIO

BridgeBio and Kyowa Kirin have formed a partnership, granting Kyowa Kirin an exclusive license to develop and commercialize infigratinib for skeletal dysplasias in Japan. BridgeBio will receive an upfront payment of $100M, royalties up to the high-twenties percent on sales in Japan, and potential additional milestone-based payments.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 12:37 pm

PAR

PAR Technology has announced the integration of its marketplace order management system, MENU Link, with Grubhub. This development is part of the expansion of the PAR MENU ecosystem, aiming to streamline operations and enhance service offerings.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 12:35 pm